ADH1B and neoplasm: To enhance the credibility of these findings, the TNMplot was further applied to validate the decreased ADH1B in tumor groups from Gene-chip data (p = 2.9e-22) and RNA-seq data (p = 1.67e-59) (Figures 3E,F).